Cargando…

Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway

We identified fermitin family member 2 (FERMT2, also known as kindlin-2) as a potential target in A375 cell line by siRNA library screening. Drugs that target mutant BRAF kinase lack durable efficacy in the treatment of melanoma because of acquired resistance, thus the identification of novel therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shaobin, Deng, Wuguo, Wang, Peng, Yan, Yue, Xie, Chuanbo, Cao, Xiaoling, Chen, Miao, Zhang, Changlin, Shi, Dingbo, Dong, Yunxian, Cheng, Pu, Xu, Hailin, Zhu, Wenkai, Hu, Zhicheng, Tang, Bing, Zhu, Jiayuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445820/
https://www.ncbi.nlm.nih.gov/pubmed/34321603
http://dx.doi.org/10.1038/s41388-021-01954-8
_version_ 1784568733986979840
author Huang, Shaobin
Deng, Wuguo
Wang, Peng
Yan, Yue
Xie, Chuanbo
Cao, Xiaoling
Chen, Miao
Zhang, Changlin
Shi, Dingbo
Dong, Yunxian
Cheng, Pu
Xu, Hailin
Zhu, Wenkai
Hu, Zhicheng
Tang, Bing
Zhu, Jiayuan
author_facet Huang, Shaobin
Deng, Wuguo
Wang, Peng
Yan, Yue
Xie, Chuanbo
Cao, Xiaoling
Chen, Miao
Zhang, Changlin
Shi, Dingbo
Dong, Yunxian
Cheng, Pu
Xu, Hailin
Zhu, Wenkai
Hu, Zhicheng
Tang, Bing
Zhu, Jiayuan
author_sort Huang, Shaobin
collection PubMed
description We identified fermitin family member 2 (FERMT2, also known as kindlin-2) as a potential target in A375 cell line by siRNA library screening. Drugs that target mutant BRAF kinase lack durable efficacy in the treatment of melanoma because of acquired resistance, thus the identification of novel therapeutic targets is needed. Immunohistochemistry was used to identify kindlin-2 expression in melanoma samples. The interaction between kindlin-2 and Rac1 or p-Rac/Cdc42 guanine nucleotide exchange factor 6 (α-Pix) was investigated. Finally, the tumor suppressive role of kindlin-2 was validated in vitro and in vivo. Analysis of clinical samples and Oncomine data showed that higher levels of kindlin-2 predicted a more advanced T stage and M stage and facilitated metastasis and recurrence. Kindlin-2 knockdown significantly inhibited melanoma growth and migration, whereas kindlin-2 overexpression had the inverse effects. Further study showed that kindlin-2 could specifically bind to p-α-Pix(S13) and Rac1 to induce a switch from the inactive Rac1-GDP conformation to the active Rac1-GTP conformation and then stimulate the downstream MAPK pathway. Moreover, we revealed that a Rac1 inhibitor suppressed melanoma growth and metastasis and the combination of the Rac1 inhibitor and vemurafenib resulted in a better therapeutic outcome than monotherapy in melanoma with high kindlin-2 expression and BRAF mutation. Our results demonstrated that kindlin-2 promoted melanoma progression, which was attributed to specific binding to p-α-Pix(S13) and Rac1 to stimulate the downstream MAPK pathway. Thus, kindlin-2 could be a potential therapeutic target for treating melanoma.
format Online
Article
Text
id pubmed-8445820
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84458202021-10-01 Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway Huang, Shaobin Deng, Wuguo Wang, Peng Yan, Yue Xie, Chuanbo Cao, Xiaoling Chen, Miao Zhang, Changlin Shi, Dingbo Dong, Yunxian Cheng, Pu Xu, Hailin Zhu, Wenkai Hu, Zhicheng Tang, Bing Zhu, Jiayuan Oncogene Article We identified fermitin family member 2 (FERMT2, also known as kindlin-2) as a potential target in A375 cell line by siRNA library screening. Drugs that target mutant BRAF kinase lack durable efficacy in the treatment of melanoma because of acquired resistance, thus the identification of novel therapeutic targets is needed. Immunohistochemistry was used to identify kindlin-2 expression in melanoma samples. The interaction between kindlin-2 and Rac1 or p-Rac/Cdc42 guanine nucleotide exchange factor 6 (α-Pix) was investigated. Finally, the tumor suppressive role of kindlin-2 was validated in vitro and in vivo. Analysis of clinical samples and Oncomine data showed that higher levels of kindlin-2 predicted a more advanced T stage and M stage and facilitated metastasis and recurrence. Kindlin-2 knockdown significantly inhibited melanoma growth and migration, whereas kindlin-2 overexpression had the inverse effects. Further study showed that kindlin-2 could specifically bind to p-α-Pix(S13) and Rac1 to induce a switch from the inactive Rac1-GDP conformation to the active Rac1-GTP conformation and then stimulate the downstream MAPK pathway. Moreover, we revealed that a Rac1 inhibitor suppressed melanoma growth and metastasis and the combination of the Rac1 inhibitor and vemurafenib resulted in a better therapeutic outcome than monotherapy in melanoma with high kindlin-2 expression and BRAF mutation. Our results demonstrated that kindlin-2 promoted melanoma progression, which was attributed to specific binding to p-α-Pix(S13) and Rac1 to stimulate the downstream MAPK pathway. Thus, kindlin-2 could be a potential therapeutic target for treating melanoma. Nature Publishing Group UK 2021-07-28 2021 /pmc/articles/PMC8445820/ /pubmed/34321603 http://dx.doi.org/10.1038/s41388-021-01954-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Huang, Shaobin
Deng, Wuguo
Wang, Peng
Yan, Yue
Xie, Chuanbo
Cao, Xiaoling
Chen, Miao
Zhang, Changlin
Shi, Dingbo
Dong, Yunxian
Cheng, Pu
Xu, Hailin
Zhu, Wenkai
Hu, Zhicheng
Tang, Bing
Zhu, Jiayuan
Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway
title Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway
title_full Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway
title_fullStr Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway
title_full_unstemmed Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway
title_short Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway
title_sort fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-pix to rac1 to activate the mapk pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445820/
https://www.ncbi.nlm.nih.gov/pubmed/34321603
http://dx.doi.org/10.1038/s41388-021-01954-8
work_keys_str_mv AT huangshaobin fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT dengwuguo fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT wangpeng fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT yanyue fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT xiechuanbo fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT caoxiaoling fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT chenmiao fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT zhangchanglin fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT shidingbo fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT dongyunxian fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT chengpu fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT xuhailin fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT zhuwenkai fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT huzhicheng fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT tangbing fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway
AT zhujiayuan fermitinfamilymember2promotesmelanomaprogressionbyenhancingthebindingofpapixtorac1toactivatethemapkpathway